| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Lipocine Inc. | Director | Stock Option (Right to Buy) | 7,174 | $22,956 | $3.2 | 04 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LPCN | Lipocine Inc. | 04 Jun 2025 | 1 | $5,644 | 4 | Director | 05 Jun 2025, 16:06 |
| LPCN | Lipocine Inc. | 05 Jun 2024 | 1 | $12,436 | 4 | Director | 07 Jun 2024, 17:43 |
| LPCN | Lipocine Inc. | 10 May 2023 | 1 | $7,968 | 4 | Director | 12 May 2023, 16:34 |
| LPCN | Lipocine Inc. | 08 Jun 2022 | 1 | $20,240 | 4 | Director | 10 Jun 2022, 11:32 |
| LPCN | Lipocine Inc. | 11 Apr 2022 | 1 | $11,600 | 4 | Director | 12 Apr 2022, 16:57 |
| LPCN | Lipocine Inc. | 11 Apr 2022 | 0 | $0 | 3 | Director | 12 Apr 2022, 16:56 |